Gastrostomy-site tumor recurrence is not always fatal.
Percutaneous gastrostomy (PEG) site tumor seeding is a rare occurrence with fewer than 30 reported cases. Reported treatment ranges from observation to wide excision with unanimously poor outcome. We report the first published case of a long-term survivor after resection of a PEG site recurrence and review our treatment approach.
Brown
T A
TA
Department of Surgical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA.
Ridge
J A
JA
Goldberg
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000556:secondary / Q000628:therapy*; D005472:Fluorouracil / Q000008:administration & dosage; D005774:Gastrostomy / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage; D009062:Mouth Neoplasms / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000473:pathology / Q000556:secondary* / Q000601:surgery*
D016685:Mitomycin; D005472:Fluorouracil